Shenzhen Edge Medical Co., Ltd. (HKG:2675)
35.70
-2.06 (-5.46%)
Sep 10, 2026, 4:08 PM HKT
Shenzhen Edge Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Strong Buy" and an average price target of $72.00. The average 1-year stock price forecast is 101.68% higher than the current stock price, while the lowest is $56.11 (+57.17%) and the highest is $99.28 (+178.10%).
Price Target: $72.00 (+101.68%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 12, 2026.
Analyst Ratings
The average analyst rating for Shenzhen Edge Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 31, 2026 |
Unknown Analyst Huachuang Securities No rating | Huachuang Securities | Buy Maintains $74.00 | Buy | Maintains | $74.00 | +107.28% | Aug 12, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $75.00 | Buy | Maintains | $75.00 | +110.08% | Jul 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $81.00 | Buy | Initiates | $81.00 | +126.89% | Apr 22, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $73.85 | Buy | Maintains | $73.85 | +106.86% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
846.20M
from 455.72M
Increased by 85.69%
Revenue Next Year
1.38B
from 846.20M
Increased by 62.90%
EPS This Year
0.24
from -0.06
EPS Next Year
0.56
from 0.24
Increased by 133.72%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.